Aller au contenu

Press review

The essentials of recent medical publications, unpacked by our newsroom into a clear, sourced digest, specialty by specialty.

Could heart health also influence cancer risk?Cardiology and Vascular Medicine

Could heart health also influence cancer risk?

By Elodie Vaz | Published on May 11, 2026 | 4 min readCardio-kidney-metabolic syndrome (CKM) refers to the coexistence of cardiovascular, renal, and metabolic disorders, including diabetes and obesity. Long studied primarily through the lens of cardiovascular risk, this syndrome is now increasingly recognized as a systemic condition affecting multiple organs throughout the body. It is already well

11 mai 2026
Immune cells and systemic lupus: a global dysregulation of the immune systemAllergology and Immunology

Immune cells and systemic lupus: a global dysregulation of the immune system

By Ana Espino | Published on May 8, 2026 | 4 min read Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by profound dysregulation of immune homeostasis, involving both innate and adaptive immunity. Recent advances, particularly through single-cell RNA sequencing and multi-omics approaches, have made it possible to identify specific alterations in cellular subpopulati

8 mai 2026
Type 2 diabetes: what the “hidden switches” inside our cells are finally revealingEndocrinology and Metabolism

Type 2 diabetes: what the “hidden switches” inside our cells are finally revealing

By Elodie Vaz | Published on May 8, 2026 | 4 min read Type 2 diabetes is characterized by chronically elevated blood glucose levels resulting from an imbalance between two essential pancreatic hormones: insulin, secreted by beta cells, and glucagon, produced by alpha cells. When insulin production or action declines, or when glucagon production becomes excessive, glucose homeostasis is disrupted.

8 mai 2026
Lyme disease: is the vaccine making a comeback?Infectiology

Lyme disease: is the vaccine making a comeback?

By Ana Espino | Published on May 7, 2026 | 4 min readLyme disease is currently the most common vector-borne disease in temperate regions, particularly in North America and Europe. It is caused by the bacterium Borrelia burgdorferi, transmitted to humans through ticks of the Ixodes genus. Its incidence continues to rise, making it a significant public health concern. Clinically, the disease initial

7 mai 2026
Lupus and pregnancy: a high-risk association?Gynecology

Lupus and pregnancy: a high-risk association?

By Ana Espino | Published on May 7, 2026 | 4 min readSystemic lupus erythematosus (SLE) is a chronic autoimmune disease that predominantly affects women of childbearing age. Pregnancy represents a major challenge in this context due to the complex interactions between the immunological, hormonal, and vascular changes inherent to gestation and disease activity. Despite therapeutic advances, pregnan

7 mai 2026
Neuropsychiatric systemic lupus erythematosus – toward new treatments ?Rhumatology

Neuropsychiatric systemic lupus erythematosus – toward new treatments ?

By Ana Espino | Published on May 6, 2026 | 4 min readSystemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of autoantibodies and systemic inflammation that can affect multiple organs, including the central nervous system. When the latter is involved, the condition is referred to as neuropsychiatric lupus (NPSLE), a common and particularly disabling form that m

6 mai 2026
Cancer: AI-measured “facial aging” emerges as a new prognostic biomarkerOncology

Cancer: AI-measured “facial aging” emerges as a new prognostic biomarker

By Elodie Vaz | Published on May 6, 2026 | 4 min readIn oncology, predicting disease progression and treatment response remains a major challenge. While tumor biomarkers, imaging, and clinical parameters already guide therapeutic decisions, they do not always capture a patient’s overall biological state. Yet biological aging, which reflects physiological frailty, strongly influences treatment tole

6 mai 2026
Asthma: men and women, the same disease?Allergology and Immunology

Asthma: men and women, the same disease?

By Ana Espino | Published on May 5, 2026 | 4 min read Asthma is a chronic inflammatory disease of the airways characterized by bronchial hyperresponsiveness, excessive mucus production, and variable inflammation. It is not a single condition, but rather a group of phenotypes based on different immunological mechanisms. A major feature of asthma is the existence of marked sex differences that evolv

5 mai 2026
Allergic rhinitis: which spray should you choose?Allergology and Immunology

Allergic rhinitis: which spray should you choose?

By Ana Espino | Published on May 5, 2026 | 4 min read Allergic rhinitis is a common chronic disease characterized by inflammation of the upper airways, with a significant impact on quality of life, school and work productivity, as well as social activities. It is often associated with asthma, which increases its clinical burden and makes it a major public health issue. Despite the existence of gui

5 mai 2026
Acute respiratory failure: toward improved survival in immunocompromised patients?Allergology and Immunology

Acute respiratory failure: toward improved survival in immunocompromised patients?

By Elodie Vaz | Published on May 5, 2026 | 4 min readAcute respiratory failure (ARF) is currently the leading cause of ICU admission among immunocompromised patients. Whether they have hematologic or solid malignancies, have undergone transplantation, or are receiving immunosuppressive therapy, this rapidly growing population remains particularly vulnerable. Despite advances in oncology, transplan

5 mai 2026
Lyme disease: towards the return of a vaccine?Infectiology

Lyme disease: towards the return of a vaccine?

By Ana Espino | Published on May 4, 2026 | 4 min readLyme disease is the most common vector-borne disease in North America and Europe, caused by the bacterium Borrelia burgdorferi. Its incidence continues to rise, making it a major public health concern. However, no vaccine is currently available for humans since the withdrawal of LYMErix in 2002 due to safety concerns and insufficient uptake. The

4 mai 2026
Cancer: exploiting the weakness of “zombie” cells to better treat tumorsOncology

Cancer: exploiting the weakness of “zombie” cells to better treat tumors

By Elodie Vaz | Published on May 4, 2026 | 4 min readIn most cancers, not all tumor cells actively proliferate. A fraction enters senescence, a state of durable arrest of cell division. Often referred to as “zombie” cells, these cells remain metabolically active without multiplying. Long considered beneficial, senescence is indeed one of the mechanisms through which chemotherapy slows tumor growth

4 mai 2026